Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size was valued at US$ 441 million in 2025 and is forecast to a readjusted size of US$ 549 million by 2032 with a CAGR of 3.2% during review period.
Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine is a biological product designed to prevent and control PRRS, a highly contagious viral disease that affects pigs. The vaccine works by stimulating the pig's immune system to produce a protective response against the PRRS virus, thereby reducing reproductive failures such as abortions and stillbirths in sows, as well as respiratory illness and mortality in piglets and growing pigs. PRRS vaccines are typically classified into modified live vaccines (MLVs) and inactivated vaccines, and they play a critical role in improving herd health and productivity in the swine industry worldwide.
The global PRRS vaccine market is primarily driven by the widespread prevalence and economic impact of Porcine Reproductive and Respiratory Syndrome in the swine industry. PRRS is one of the most devastating diseases affecting pigs, causing significant reproductive losses in breeding herds and severe respiratory distress in growing pigs. The virus's ability to mutate and persist in herds has made it difficult to eradicate, leading to chronic infections and substantial financial losses for pig farmers. As a result, governments and veterinary authorities in major pork-producing countries such as China, the United States, and countries in the European Union have emphasized vaccination as a critical component of disease control programs. Additionally, rising global pork consumption is pressuring producers to maintain healthier herds and ensure consistent productivity, further boosting demand for effective PRRS vaccines. Technological advancements in vaccine formulation?such as the development of region-specific or genotype-specific modified live vaccines (MLVs)?have improved vaccine efficacy, making immunization a more reliable and widely accepted preventive measure. Moreover, increasing biosecurity awareness and the integration of vaccination into herd health management systems are reinforcing the growth of the PRRS vaccine market globally.
Despite its importance, the PRRS vaccine market faces several challenges that limit its effectiveness and adoption in certain regions. One of the primary issues is the virus's high genetic variability, which complicates the development of universally effective vaccines. The presence of multiple genotypes and frequent mutations means that vaccine strains may not provide cross-protection against all circulating variants, leading to inconsistent results and partial immunity in vaccinated herds. Additionally, modified live vaccines (MLVs), while generally more effective than inactivated ones, carry risks of reversion to virulence or recombination with field strains, which raises safety concerns among producers and regulatory bodies. In developing regions, limited access to veterinary services, cold chain logistics, and affordability issues further hinder the widespread adoption of PRRS vaccination programs. Moreover, there remains a lack of standardized vaccination protocols across countries, and vaccine performance can vary depending on farm conditions, pig genetics, and co-infections with other pathogens. These factors make disease management complex and can reduce confidence in vaccination strategies. Overcoming these challenges requires continued investment in research and development of next-generation vaccines, improved diagnostic tools for strain identification, and stronger government support for vaccination campaigns and swine health education.
This report is a detailed and comprehensive analysis for global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include China Animal Husbandry Co., Ltd., Boehringer Ingelheim, MSD Animal Health, Sinopharm Animal Health, Ceva, Ruipu Biological, Qilu Animal Health, Dahuanong, CAVAC, Komipharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, with price, sales quantity, revenue, and global market share of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine from 2021 to 2026.
Chapter 3, the Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.
Chapter 14 and 15, to describe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales channel, distributors, customers, research findings and conclusion.
Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine is a biological product designed to prevent and control PRRS, a highly contagious viral disease that affects pigs. The vaccine works by stimulating the pig's immune system to produce a protective response against the PRRS virus, thereby reducing reproductive failures such as abortions and stillbirths in sows, as well as respiratory illness and mortality in piglets and growing pigs. PRRS vaccines are typically classified into modified live vaccines (MLVs) and inactivated vaccines, and they play a critical role in improving herd health and productivity in the swine industry worldwide.
The global PRRS vaccine market is primarily driven by the widespread prevalence and economic impact of Porcine Reproductive and Respiratory Syndrome in the swine industry. PRRS is one of the most devastating diseases affecting pigs, causing significant reproductive losses in breeding herds and severe respiratory distress in growing pigs. The virus's ability to mutate and persist in herds has made it difficult to eradicate, leading to chronic infections and substantial financial losses for pig farmers. As a result, governments and veterinary authorities in major pork-producing countries such as China, the United States, and countries in the European Union have emphasized vaccination as a critical component of disease control programs. Additionally, rising global pork consumption is pressuring producers to maintain healthier herds and ensure consistent productivity, further boosting demand for effective PRRS vaccines. Technological advancements in vaccine formulation?such as the development of region-specific or genotype-specific modified live vaccines (MLVs)?have improved vaccine efficacy, making immunization a more reliable and widely accepted preventive measure. Moreover, increasing biosecurity awareness and the integration of vaccination into herd health management systems are reinforcing the growth of the PRRS vaccine market globally.
Despite its importance, the PRRS vaccine market faces several challenges that limit its effectiveness and adoption in certain regions. One of the primary issues is the virus's high genetic variability, which complicates the development of universally effective vaccines. The presence of multiple genotypes and frequent mutations means that vaccine strains may not provide cross-protection against all circulating variants, leading to inconsistent results and partial immunity in vaccinated herds. Additionally, modified live vaccines (MLVs), while generally more effective than inactivated ones, carry risks of reversion to virulence or recombination with field strains, which raises safety concerns among producers and regulatory bodies. In developing regions, limited access to veterinary services, cold chain logistics, and affordability issues further hinder the widespread adoption of PRRS vaccination programs. Moreover, there remains a lack of standardized vaccination protocols across countries, and vaccine performance can vary depending on farm conditions, pig genetics, and co-infections with other pathogens. These factors make disease management complex and can reduce confidence in vaccination strategies. Overcoming these challenges requires continued investment in research and development of next-generation vaccines, improved diagnostic tools for strain identification, and stronger government support for vaccination campaigns and swine health education.
This report is a detailed and comprehensive analysis for global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include China Animal Husbandry Co., Ltd., Boehringer Ingelheim, MSD Animal Health, Sinopharm Animal Health, Ceva, Ruipu Biological, Qilu Animal Health, Dahuanong, CAVAC, Komipharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Live vaccines
- Inactivated vaccines
- Government bidding
- Market sales
- China Animal Husbandry Co., Ltd.
- Boehringer Ingelheim
- MSD Animal Health
- Sinopharm Animal Health
- Ceva
- Ruipu Biological
- Qilu Animal Health
- Dahuanong
- CAVAC
- Komipharm
- Agrovet
- Bioveta
- Jinyu
- Phibro Animal Health
- Tiankang
- Zoetis
- Yongshun Biological
- Pulike Biological
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, with price, sales quantity, revenue, and global market share of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine from 2021 to 2026.
Chapter 3, the Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.
Chapter 14 and 15, to describe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Live vaccines
1.3.3 Inactivated vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Government bidding
1.4.3 Market sales
1.5 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size & Forecast
1.5.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (2021-2032)
1.5.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 China Animal Husbandry Co., Ltd.
2.1.1 China Animal Husbandry Co., Ltd. Details
2.1.2 China Animal Husbandry Co., Ltd. Major Business
2.1.3 China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.1.4 China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 China Animal Husbandry Co., Ltd. Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.2.4 Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 MSD Animal Health
2.3.1 MSD Animal Health Details
2.3.2 MSD Animal Health Major Business
2.3.3 MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.3.4 MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 MSD Animal Health Recent Developments/Updates
2.4 Sinopharm Animal Health
2.4.1 Sinopharm Animal Health Details
2.4.2 Sinopharm Animal Health Major Business
2.4.3 Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.4.4 Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Sinopharm Animal Health Recent Developments/Updates
2.5 Ceva
2.5.1 Ceva Details
2.5.2 Ceva Major Business
2.5.3 Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.5.4 Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Ceva Recent Developments/Updates
2.6 Ruipu Biological
2.6.1 Ruipu Biological Details
2.6.2 Ruipu Biological Major Business
2.6.3 Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.6.4 Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Ruipu Biological Recent Developments/Updates
2.7 Qilu Animal Health
2.7.1 Qilu Animal Health Details
2.7.2 Qilu Animal Health Major Business
2.7.3 Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.7.4 Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Qilu Animal Health Recent Developments/Updates
2.8 Dahuanong
2.8.1 Dahuanong Details
2.8.2 Dahuanong Major Business
2.8.3 Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.8.4 Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Dahuanong Recent Developments/Updates
2.9 CAVAC
2.9.1 CAVAC Details
2.9.2 CAVAC Major Business
2.9.3 CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.9.4 CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 CAVAC Recent Developments/Updates
2.10 Komipharm
2.10.1 Komipharm Details
2.10.2 Komipharm Major Business
2.10.3 Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.10.4 Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Komipharm Recent Developments/Updates
2.11 Agrovet
2.11.1 Agrovet Details
2.11.2 Agrovet Major Business
2.11.3 Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.11.4 Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Agrovet Recent Developments/Updates
2.12 Bioveta
2.12.1 Bioveta Details
2.12.2 Bioveta Major Business
2.12.3 Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.12.4 Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Bioveta Recent Developments/Updates
2.13 Jinyu
2.13.1 Jinyu Details
2.13.2 Jinyu Major Business
2.13.3 Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.13.4 Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Jinyu Recent Developments/Updates
2.14 Phibro Animal Health
2.14.1 Phibro Animal Health Details
2.14.2 Phibro Animal Health Major Business
2.14.3 Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.14.4 Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Phibro Animal Health Recent Developments/Updates
2.15 Tiankang
2.15.1 Tiankang Details
2.15.2 Tiankang Major Business
2.15.3 Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.15.4 Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Tiankang Recent Developments/Updates
2.16 Zoetis
2.16.1 Zoetis Details
2.16.2 Zoetis Major Business
2.16.3 Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.16.4 Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Zoetis Recent Developments/Updates
2.17 Yongshun Biological
2.17.1 Yongshun Biological Details
2.17.2 Yongshun Biological Major Business
2.17.3 Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.17.4 Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Yongshun Biological Recent Developments/Updates
2.18 Pulike Biological
2.18.1 Pulike Biological Details
2.18.2 Pulike Biological Major Business
2.18.3 Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.18.4 Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Pulike Biological Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) VACCINE BY MANUFACTURER
3.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturer (2021-2026)
3.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturer Market Share in 2025
3.4.3 Top 6 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturer Market Share in 2025
3.5 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Overall Company Footprint Analysis
3.5.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Region Footprint
3.5.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Company Product Type Footprint
3.5.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region
4.1.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Region (2021-2032)
4.1.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2021-2032)
4.1.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Region (2021-2032)
4.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032)
4.3 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032)
4.4 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032)
4.5 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032)
4.6 Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2032)
5.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Type (2021-2032)
5.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2032)
6.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Application (2021-2032)
6.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2032)
7.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2032)
7.3 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
7.3.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2032)
7.3.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2032)
8.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2032)
8.3 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
8.3.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2032)
8.3.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region
9.3.1 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2032)
10.2 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2032)
10.3 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
10.3.1 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2032)
10.3.2 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
11.3.1 Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
12.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
12.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
13.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Typical Distributors
14.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Live vaccines
1.3.3 Inactivated vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Government bidding
1.4.3 Market sales
1.5 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size & Forecast
1.5.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (2021-2032)
1.5.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 China Animal Husbandry Co., Ltd.
2.1.1 China Animal Husbandry Co., Ltd. Details
2.1.2 China Animal Husbandry Co., Ltd. Major Business
2.1.3 China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.1.4 China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 China Animal Husbandry Co., Ltd. Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.2.4 Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 MSD Animal Health
2.3.1 MSD Animal Health Details
2.3.2 MSD Animal Health Major Business
2.3.3 MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.3.4 MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 MSD Animal Health Recent Developments/Updates
2.4 Sinopharm Animal Health
2.4.1 Sinopharm Animal Health Details
2.4.2 Sinopharm Animal Health Major Business
2.4.3 Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.4.4 Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Sinopharm Animal Health Recent Developments/Updates
2.5 Ceva
2.5.1 Ceva Details
2.5.2 Ceva Major Business
2.5.3 Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.5.4 Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Ceva Recent Developments/Updates
2.6 Ruipu Biological
2.6.1 Ruipu Biological Details
2.6.2 Ruipu Biological Major Business
2.6.3 Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.6.4 Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Ruipu Biological Recent Developments/Updates
2.7 Qilu Animal Health
2.7.1 Qilu Animal Health Details
2.7.2 Qilu Animal Health Major Business
2.7.3 Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.7.4 Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Qilu Animal Health Recent Developments/Updates
2.8 Dahuanong
2.8.1 Dahuanong Details
2.8.2 Dahuanong Major Business
2.8.3 Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.8.4 Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Dahuanong Recent Developments/Updates
2.9 CAVAC
2.9.1 CAVAC Details
2.9.2 CAVAC Major Business
2.9.3 CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.9.4 CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 CAVAC Recent Developments/Updates
2.10 Komipharm
2.10.1 Komipharm Details
2.10.2 Komipharm Major Business
2.10.3 Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.10.4 Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Komipharm Recent Developments/Updates
2.11 Agrovet
2.11.1 Agrovet Details
2.11.2 Agrovet Major Business
2.11.3 Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.11.4 Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Agrovet Recent Developments/Updates
2.12 Bioveta
2.12.1 Bioveta Details
2.12.2 Bioveta Major Business
2.12.3 Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.12.4 Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Bioveta Recent Developments/Updates
2.13 Jinyu
2.13.1 Jinyu Details
2.13.2 Jinyu Major Business
2.13.3 Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.13.4 Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Jinyu Recent Developments/Updates
2.14 Phibro Animal Health
2.14.1 Phibro Animal Health Details
2.14.2 Phibro Animal Health Major Business
2.14.3 Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.14.4 Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Phibro Animal Health Recent Developments/Updates
2.15 Tiankang
2.15.1 Tiankang Details
2.15.2 Tiankang Major Business
2.15.3 Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.15.4 Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Tiankang Recent Developments/Updates
2.16 Zoetis
2.16.1 Zoetis Details
2.16.2 Zoetis Major Business
2.16.3 Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.16.4 Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Zoetis Recent Developments/Updates
2.17 Yongshun Biological
2.17.1 Yongshun Biological Details
2.17.2 Yongshun Biological Major Business
2.17.3 Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.17.4 Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Yongshun Biological Recent Developments/Updates
2.18 Pulike Biological
2.18.1 Pulike Biological Details
2.18.2 Pulike Biological Major Business
2.18.3 Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.18.4 Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Pulike Biological Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) VACCINE BY MANUFACTURER
3.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturer (2021-2026)
3.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturer Market Share in 2025
3.4.3 Top 6 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturer Market Share in 2025
3.5 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Overall Company Footprint Analysis
3.5.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Region Footprint
3.5.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Company Product Type Footprint
3.5.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region
4.1.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Region (2021-2032)
4.1.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2021-2032)
4.1.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Region (2021-2032)
4.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032)
4.3 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032)
4.4 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032)
4.5 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032)
4.6 Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2032)
5.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Type (2021-2032)
5.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2032)
6.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Application (2021-2032)
6.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2032)
7.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2032)
7.3 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
7.3.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2032)
7.3.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2032)
8.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2032)
8.3 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
8.3.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2032)
8.3.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region
9.3.1 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2032)
10.2 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2032)
10.3 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
10.3.1 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2032)
10.3.2 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
11.3.1 Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
12.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
12.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
13.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Typical Distributors
14.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF FIGURES
Table 1. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. China Animal Husbandry Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. China Animal Husbandry Co., Ltd. Major Business
Table 5. China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 6. China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. China Animal Husbandry Co., Ltd. Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 11. Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 14. MSD Animal Health Major Business
Table 15. MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 16. MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. MSD Animal Health Recent Developments/Updates
Table 18. Sinopharm Animal Health Basic Information, Manufacturing Base and Competitors
Table 19. Sinopharm Animal Health Major Business
Table 20. Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 21. Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Sinopharm Animal Health Recent Developments/Updates
Table 23. Ceva Basic Information, Manufacturing Base and Competitors
Table 24. Ceva Major Business
Table 25. Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 26. Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Ceva Recent Developments/Updates
Table 28. Ruipu Biological Basic Information, Manufacturing Base and Competitors
Table 29. Ruipu Biological Major Business
Table 30. Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 31. Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Ruipu Biological Recent Developments/Updates
Table 33. Qilu Animal Health Basic Information, Manufacturing Base and Competitors
Table 34. Qilu Animal Health Major Business
Table 35. Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 36. Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Qilu Animal Health Recent Developments/Updates
Table 38. Dahuanong Basic Information, Manufacturing Base and Competitors
Table 39. Dahuanong Major Business
Table 40. Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 41. Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Dahuanong Recent Developments/Updates
Table 43. CAVAC Basic Information, Manufacturing Base and Competitors
Table 44. CAVAC Major Business
Table 45. CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 46. CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. CAVAC Recent Developments/Updates
Table 48. Komipharm Basic Information, Manufacturing Base and Competitors
Table 49. Komipharm Major Business
Table 50. Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 51. Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Komipharm Recent Developments/Updates
Table 53. Agrovet Basic Information, Manufacturing Base and Competitors
Table 54. Agrovet Major Business
Table 55. Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 56. Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Agrovet Recent Developments/Updates
Table 58. Bioveta Basic Information, Manufacturing Base and Competitors
Table 59. Bioveta Major Business
Table 60. Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 61. Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Bioveta Recent Developments/Updates
Table 63. Jinyu Basic Information, Manufacturing Base and Competitors
Table 64. Jinyu Major Business
Table 65. Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 66. Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Jinyu Recent Developments/Updates
Table 68. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
Table 69. Phibro Animal Health Major Business
Table 70. Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 71. Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Phibro Animal Health Recent Developments/Updates
Table 73. Tiankang Basic Information, Manufacturing Base and Competitors
Table 74. Tiankang Major Business
Table 75. Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 76. Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Tiankang Recent Developments/Updates
Table 78. Zoetis Basic Information, Manufacturing Base and Competitors
Table 79. Zoetis Major Business
Table 80. Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 81. Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Zoetis Recent Developments/Updates
Table 83. Yongshun Biological Basic Information, Manufacturing Base and Competitors
Table 84. Yongshun Biological Major Business
Table 85. Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 86. Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. Yongshun Biological Recent Developments/Updates
Table 88. Pulike Biological Basic Information, Manufacturing Base and Competitors
Table 89. Pulike Biological Major Business
Table 90. Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 91. Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Pulike Biological Recent Developments/Updates
Table 93. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 94. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 95. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 96. Market Position of Manufacturers in Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 97. Head Office and Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Site of Key Manufacturer
Table 98. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Company Product Type Footprint
Table 99. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Company Product Application Footprint
Table 100. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine New Market Entrants and Barriers to Market Entry
Table 101. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 103. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 104. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 105. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 106. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 107. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 108. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 109. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 110. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 111. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Type (2021-2026) & (USD Million)
Table 112. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Type (2027-2032) & (USD Million)
Table 113. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 114. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 115. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 116. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 117. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Application (2021-2026) & (USD Million)
Table 118. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Application (2027-2032) & (USD Million)
Table 119. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 120. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 121. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 122. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 123. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 124. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 125. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 126. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 127. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 128. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 129. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 130. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 131. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 132. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 133. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 134. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 135. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 136. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 137. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 138. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 139. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 140. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 141. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 142. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 143. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 144. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 145. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 146. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 147. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 148. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 149. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 150. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 151. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 152. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 153. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 154. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 155. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 156. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 157. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 158. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 159. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 160. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 161. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Raw Material
Table 162. Key Manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Raw Materials
Table 163. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Typical Distributors
Table 164. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Picture
Figure 2. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type in 2025
Figure 4. Live vaccines Examples
Figure 5. Inactivated vaccines Examples
Figure 6. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application in 2025
Figure 8. Government bidding Examples
Figure 9. Market sales Examples
Figure 10. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 11. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 12. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (2021-2032) & (K Dose)
Figure 13. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (2021-2032) & (US$/Dose)
Figure 14. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Manufacturer in 2025
Figure 15. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturer in 2025
Figure 16. Producer Shipments of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 17. Top 3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 18. Top 6 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 19. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 20. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 21. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 22. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 23. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 24. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 25. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 26. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 27. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Type (2021-2032)
Figure 28. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 29. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 30. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032)
Figure 31. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 32. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 33. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 34. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 35. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 36. United States Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 37. Canada Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 38. Mexico Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 39. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 40. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 41. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 42. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 43. Germany Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 44. France Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 45. United Kingdom Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 46. Russia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 47. Italy Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 49. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 50. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 51. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 52. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 53. Japan Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 54. South Korea Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 55. India Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 56. Southeast Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 57. Australia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 58. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 59. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 60. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 61. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 62. Brazil Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 63. Argentina Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 64. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 65. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 66. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 67. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 68. Turkey Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 69. Egypt Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 70. Saudi Arabia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 71. South Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 72. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
Figure 73. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
Figure 74. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in 2025
Figure 77. Manufacturing Process Analysis of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Figure 78. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Table 1. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. China Animal Husbandry Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. China Animal Husbandry Co., Ltd. Major Business
Table 5. China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 6. China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. China Animal Husbandry Co., Ltd. Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 11. Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 14. MSD Animal Health Major Business
Table 15. MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 16. MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. MSD Animal Health Recent Developments/Updates
Table 18. Sinopharm Animal Health Basic Information, Manufacturing Base and Competitors
Table 19. Sinopharm Animal Health Major Business
Table 20. Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 21. Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Sinopharm Animal Health Recent Developments/Updates
Table 23. Ceva Basic Information, Manufacturing Base and Competitors
Table 24. Ceva Major Business
Table 25. Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 26. Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Ceva Recent Developments/Updates
Table 28. Ruipu Biological Basic Information, Manufacturing Base and Competitors
Table 29. Ruipu Biological Major Business
Table 30. Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 31. Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Ruipu Biological Recent Developments/Updates
Table 33. Qilu Animal Health Basic Information, Manufacturing Base and Competitors
Table 34. Qilu Animal Health Major Business
Table 35. Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 36. Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Qilu Animal Health Recent Developments/Updates
Table 38. Dahuanong Basic Information, Manufacturing Base and Competitors
Table 39. Dahuanong Major Business
Table 40. Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 41. Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Dahuanong Recent Developments/Updates
Table 43. CAVAC Basic Information, Manufacturing Base and Competitors
Table 44. CAVAC Major Business
Table 45. CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 46. CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. CAVAC Recent Developments/Updates
Table 48. Komipharm Basic Information, Manufacturing Base and Competitors
Table 49. Komipharm Major Business
Table 50. Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 51. Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Komipharm Recent Developments/Updates
Table 53. Agrovet Basic Information, Manufacturing Base and Competitors
Table 54. Agrovet Major Business
Table 55. Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 56. Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Agrovet Recent Developments/Updates
Table 58. Bioveta Basic Information, Manufacturing Base and Competitors
Table 59. Bioveta Major Business
Table 60. Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 61. Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Bioveta Recent Developments/Updates
Table 63. Jinyu Basic Information, Manufacturing Base and Competitors
Table 64. Jinyu Major Business
Table 65. Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 66. Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Jinyu Recent Developments/Updates
Table 68. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
Table 69. Phibro Animal Health Major Business
Table 70. Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 71. Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Phibro Animal Health Recent Developments/Updates
Table 73. Tiankang Basic Information, Manufacturing Base and Competitors
Table 74. Tiankang Major Business
Table 75. Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 76. Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Tiankang Recent Developments/Updates
Table 78. Zoetis Basic Information, Manufacturing Base and Competitors
Table 79. Zoetis Major Business
Table 80. Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 81. Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Zoetis Recent Developments/Updates
Table 83. Yongshun Biological Basic Information, Manufacturing Base and Competitors
Table 84. Yongshun Biological Major Business
Table 85. Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 86. Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. Yongshun Biological Recent Developments/Updates
Table 88. Pulike Biological Basic Information, Manufacturing Base and Competitors
Table 89. Pulike Biological Major Business
Table 90. Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 91. Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Pulike Biological Recent Developments/Updates
Table 93. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 94. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 95. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 96. Market Position of Manufacturers in Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 97. Head Office and Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Site of Key Manufacturer
Table 98. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Company Product Type Footprint
Table 99. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Company Product Application Footprint
Table 100. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine New Market Entrants and Barriers to Market Entry
Table 101. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 103. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 104. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 105. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 106. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 107. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 108. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 109. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 110. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 111. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Type (2021-2026) & (USD Million)
Table 112. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Type (2027-2032) & (USD Million)
Table 113. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 114. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 115. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 116. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 117. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Application (2021-2026) & (USD Million)
Table 118. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Application (2027-2032) & (USD Million)
Table 119. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 120. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 121. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 122. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 123. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 124. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 125. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 126. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 127. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 128. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 129. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 130. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 131. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 132. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 133. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 134. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 135. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 136. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 137. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 138. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 139. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 140. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 141. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 142. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 143. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 144. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 145. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 146. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 147. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 148. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 149. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 150. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 151. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 152. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 153. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 154. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 155. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 156. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 157. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 158. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 159. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 160. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 161. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Raw Material
Table 162. Key Manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Raw Materials
Table 163. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Typical Distributors
Table 164. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Picture
Figure 2. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type in 2025
Figure 4. Live vaccines Examples
Figure 5. Inactivated vaccines Examples
Figure 6. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application in 2025
Figure 8. Government bidding Examples
Figure 9. Market sales Examples
Figure 10. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 11. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 12. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity (2021-2032) & (K Dose)
Figure 13. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (2021-2032) & (US$/Dose)
Figure 14. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Manufacturer in 2025
Figure 15. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturer in 2025
Figure 16. Producer Shipments of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 17. Top 3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 18. Top 6 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 19. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 20. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 21. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 22. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 23. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 24. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 25. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 26. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 27. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Type (2021-2032)
Figure 28. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 29. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 30. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032)
Figure 31. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 32. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 33. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 34. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 35. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 36. United States Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 37. Canada Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 38. Mexico Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 39. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 40. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 41. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 42. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 43. Germany Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 44. France Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 45. United Kingdom Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 46. Russia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 47. Italy Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 49. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 50. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 51. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 52. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 53. Japan Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 54. South Korea Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 55. India Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 56. Southeast Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 57. Australia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 58. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 59. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 60. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 61. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 62. Brazil Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 63. Argentina Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 64. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 65. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 66. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 67. Middle East & Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 68. Turkey Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 69. Egypt Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 70. Saudi Arabia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 71. South Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 72. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
Figure 73. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
Figure 74. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in 2025
Figure 77. Manufacturing Process Analysis of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Figure 78. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
